Erasca, Inc. (ERAS) Balance Sheet

NASDAQ: ERASAssets, liabilities, debt and equity over 7 years.

ERAS balance sheet, 2025

December 31, 2025 · U.S. dollars

$396.2M assets = $71.0M liabilities + $325.2M equity

What it owns$396.2MCash & ST investments: $276.1M (69.7%)Cash & ST investments$276.1M · 70%Receivables: $2.5M (0.6%)Other current: $7.7M (1.9%)PP&E: $42.3M (10.7%)PP&E $42.3MLT investments: $65.7M (16.6%)LT investments$65.7M · 17%Other non-current: $1.9M (0.5%)=How it is financed$396.2MCurrent liabilities: $28.5M (7.2%)Current liabilities $28.5MOther LT liabilities: $42.5M (10.7%)$42.5MShareholders’ equity: $325.2M (82.1%)Shareholders’ equity$325.2M · 82%

Both columns are drawn to the same scale: what ERAS owns equals what it owes plus shareholders’ equity. Hover a block for its value.

ERAS financial health

Debt / equity0.14
Low leverage · $0.14 of debt for each $1 of equity
Equity / assets82.1%
Equity-funded · of assets funded by shareholders
Cash / debt585.7%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

ERAS balance sheet trends, 2019–2025

Erasca, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$55.5M2019$396.2M2025+38.8%/yr
Total liabilities$69.1M2019$71.0M2025+0.4%/yr
Shareholders’ equity−$13.6M2019$325.2M2025—
Cash & short-term investments$50.4M2019$276.1M2025+32.8%/yr
Total debt$3.7M2019$47.1M2025+52.9%/yr
Net cash (debt)$46.7M2019$228.9M2025+$182.3M
Working capital$48.4M2019$257.7M2025+$209.4M
Book value per share−$0.142019$1.152025—
Debt / equity0.0420210.142025+0.10
Shares outstanding95.2M2019283.5M2025+20.0%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ERAS assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

ERAS liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

ERAS debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

ERAS balance sheet

Erasca, Inc. annual balance sheet
2025202420232022202120202019
Assets
Cash & short-term investments$276.1M$298.3M$312.4M$435.6M$459.2M$118.7M$50.4M
Cash & equivalents$73.8M$67.7M$93.1M$284.2M$360.5M$65.4M$29.6M
Short-term investments$202.3M$230.6M$219.3M$151.4M$54.0M$53.3M$20.8M
Receivables$2.5M$2.3M$0$0$100,000$0$0
Inventory$0$0$0$0$0$0$0
Other current assets$7.7M$8.2M$8.3M$8.9M$0$1.3M$752,000
Total current assets$286.2M$308.8M$320.7M$444.5M$420.0M$120.0M$51.1M
Property, plant & equipment (net)$42.3M$48.5M$60.2M$65.2M$33.3M$4.1M$4.3M
Goodwill & intangible assets$0$0$0$0$0$0$0
Long-term investments$65.7M$142.2M$9.6M$0$44.8M$0$0
Other non-current assets$1.9M$3.0M$4.8M$5.2M$3.3M$763,000$56,000
Total assets$396.2M$502.5M$395.3M$514.9M$501.4M$124.8M$55.5M
Liabilities
Accounts payable$981,000$468,000$2.0M$23.0M$4.7M$878,000$1.4M
Short-term debt$5.1M$9.2M$4.0M$2.6M$570,000$877,000$726,000
Deferred revenue————$18.5M$9.4M—
Total current liabilities$28.5M$31.4M$26.2M$48.7M$26.4M$13.7M$2.8M
Long-term debt$0$0$0$0$0$0$0
Lease obligations$47.1M$51.9M$55.9M$55.1M$18.8M$3.0M$3.7M
Other long-term liabilities$42.5M$47.6M$52.5M$54.4M$18.5M$225.1M$66.4M
Total liabilities$71.0M$79.0M$78.6M$103.1M$44.9M$238.8M$69.1M
Shareholders' equity
Common stock & paid-in capital$28,000$28,000$15,000$15,000$12,000$3,000$3,000
Retained earnings (deficit)−$892.2M−$767.7M−$606.0M−$481.0M−$238.2M−$115.4M−$13.7M
Accumulated other comprehensive income$628,000$405,000$77,000−$1.0M−$162,000$2,000$11,000
Total shareholders' equity$325.2M$423.5M$316.7M$411.9M$456.5M−$114.0M−$13.6M
Key figures
Total debt$47.1M$51.9M$55.9M$55.1M$18.8M$3.0M$3.7M
Net cash (debt)$228.9M$246.4M$256.5M$380.5M$440.5M$115.7M$46.7M
Working capital$257.7M$277.4M$294.5M$395.8M$393.6M$106.3M$48.4M
Tangible book value$325.2M$423.5M$316.7M$411.9M$456.5M−$114.0M−$13.6M
Book value per share$1.15$1.81$2.64$4.22$4.79—−$0.14
Shares outstanding283.5M233.8M120.1M97.6M95.3M—95.2M
Current ratio10.049.8412.269.1315.928.7718.59
Quick ratio9.779.5811.948.9517.418.6818.32
Debt / equity0.140.120.180.130.04——
Equity / assets82.1%84.3%80.1%80.0%91.0%−91.3%−24.5%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 12, 2026); data from EODHD.

ERAS financial position

At the end of fiscal 2025 (December 31, 2025), Erasca had total assets of $396.2 million (down 21.2% from a year earlier), total liabilities of $71.0 million and shareholders' equity of $325.2 million. It held $276.1 million in cash and short-term investments against $47.1 million of debt, a net cash position of $228.9 million. Its current ratio was 10.04. In the latest quarter (ended June 30, 2026) total assets were $435.1 million and equity $361.9 million.

Related: ERAS income statement, ERAS cash flow statement, ERAS key metrics. See the ERAS stock overview for the latest quote and news.

ERAS balance sheet FAQ

What are Erasca's total assets?

Erasca reported total assets of $396.2 million at the end of fiscal 2025 (December 31, 2025), compared with $502.5 million a year earlier.

How much debt does Erasca have?

Erasca had $47.1 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.14.

How much cash does Erasca have?

Erasca held $276.1 million in cash and short-term investments at the end of fiscal 2025; with $47.1 million of debt that is net cash of $228.9 million.

What is Erasca's book value?

Erasca's shareholders' equity (book value) was $325.2 million at the end of fiscal 2025, or $1.15 per share.

What is Erasca's current ratio?

Erasca had current assets of $286.2 million and current liabilities of $28.5 million, a current ratio of 10.04 (it can cover its short-term obligations).

Biotechnology: balance sheet